Part Number
Part Number:
NSN:
NIIN:
Item Name:
LITHIUM CITRATE SYRUP , USP
Definition:
CAGE Information
| Code | Company |
|---|---|
| 00QD1 | MORTON GROVE PHARMACEUTICALS INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 8.000 MILLIEQUIVALENTS LITHIUM ION PER 5 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| FEAT | SPECIAL FEATURES | EQUIVALENT TO 300 MG. LITHIUM CARBONATE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 480.000 MILLILITERS OR 500.000 MILLILITERS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LITHIUM CITRATE SYRUP USP 8MEG/5ML 480ML BT |